Live cell imaging is the study of cells in real time using the images obtained from screening systems and microscopes. The technology has altered the approach of scientists to study proteins, molecular interactions and internal structures of cells, cellular processes and understand biological functions. It enables them to observe cells to get an in-depth analysis instead of studying the images of fixed cells. Information with more precision can be obtained using live cell imaging, which plays a crucial role in understanding cell dynamics in research fields such as immunology, genetics, neurology, microbiology and others. Technological advancements in live cell imaging will fulfil the demands of academic institutes, government organizations, pharmaceutical companies and diagnostic laboratories.
The key factors driving the world live cell imaging market are adoption of high-content screening techniques, huge government funding for cell based research, and rising incidences of cancer worldwide. However, the scarcity of skilled professionals and high cost of high-content screening systems are some of the major factors restraining the growth of the market. The adoption of high-content screening systems for primary screening and applications of live cell imaging in personalized medicines presents growth opportunities for the market players.
World live cell imaging market is segmented on the basis of product, technology, application and geography. Based on product, the market is categorized into equipment, consumable and software. Based on technology, the market is classified into fluorescence recovery after photobleaching (fading) and high-content screening. On the basis of application, the market is categorized into cell biology, stem cells and drug discovery. Geographically, the market is segmented into North America, Asia, Europe, and LAMEA.
The key manufacturers profiled in the report are Carl Zeiss AG, Danaher Corporation (Leica Microsystems), Becton Dickinson & Company, GE Healthcare (Subsidiary of General Electric Company), Molecular Devices LLC, Sigma-Aldrich Corporation, Nikon Corporation, Olympus Corporation, PerkinElmer Inc., and Thermo Fisher Scientific Inc. Partnerships, joint ventures and collaborations are some of the few strategies adopted by the companies to gain a strong foothold in the market.
KEY BENEFITS FOR STAKEHOLDERS:
KEY MARKET SEGMENTS:
SIMILAR MARKET STUDIES
Blood Market by Product [Whole Blood Collection (System and Reagents), Source Plasma Collections (System and Reagents) Blood Therapeutics (IVIG, Albumin, Hyperimmune, Factor VIII, Factor IX, and Others), Blood Typing Products (System and Reagents), Blood Screening (Systems and Reagents), Blood Processing Equipment & Associated Products (System and Reagents)] and End User (Blood & Blood Component Bank, Diagnostic Laboratories, Ambulatory Surgical Centers, Hospitals, and Others): Global Opportunity Analysis and Industry Forecast, 2017-2023
Blood is a major necessity for patients suffering from injuries and viral infections, which require blood transfusion. The patients are either given whole blood or blood components for quick recovery and healing, resulting into increased demand for blood banks.
July 2017 | $5370 | View Details >>
The global Vernier Caliper market is valued at XX million USD in 2016 and is expected to reach XX million USD by the end of 2022, growing at a CAGR of XX% between 2016 and 2022. Japan plays an important role in global market, with market size of xx million ...
July 2017 | $3085 | View Details >>
UPCOMING MARKET RESEARCH REPORTS
2017 © Copyright Big Market Research